Key Events This Week
2 Feb: Technical momentum shifts amid mixed market signals
4 Feb: Upgrade to Hold on technical and valuation improvements
4 Feb: Signs of technical momentum shift with mixed indicator signals
6 Feb: Week closes at Rs.867.50 (+8.32%) outperforming Sensex

Medplus Health Services Ltd Upgraded to Hold on Technical and Valuation Improvements
2026-02-04 08:33:55Medplus Health Services Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and valuation metrics amid steady financial performance. The upgrade, effective from 3 February 2026, is underpinned by a shift in technical trends, attractive valuation relative to peers, and consistent quarterly results, although certain fundamental weaknesses remain.
Read full news article
Medplus Health Services Ltd Shows Signs of Technical Momentum Shift Amid Mixed Indicator Signals
2026-02-04 08:07:20Medplus Health Services Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by a combination of technical indicators, including MACD, Bollinger Bands, and KST, signalling potential upward price movement despite some mixed signals from moving averages and RSI. The stock’s recent performance outpaces the broader market, reflecting renewed investor interest and a possible re-rating in the retailing sector.
Read full news articleWhy is Medplus Health Services Ltd falling/rising?
2026-02-04 01:24:16
Strong Price Performance Against Benchmarks
Medplus Health’s recent price movement has outpaced the broader market and its sector peers. Over the past week, the stock has gained 11.20%, substantially higher than the Sensex’s 2.30% rise. Similarly, the one-month return of 5.21% contrasts with the Sensex’s decline of 2.36%. Year-to-date, the stock has appreciated by 6.80%, while the Sensex has fallen by 1.74%. Even on a one-year horizon, Medplus Health has delivered a 13.36% return, outperforming the Sensex’s 8.49% gain. These figures underscore the stock’s resilience and appeal amid broader market volatility.
Positive Momentum in Trading and Sector Dynamics
On 03-Feb, Medplus Health outperformed the retailing sector by 2.09%, with the sector itse...
Read full news article
Medplus Health Services Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-02-02 08:06:22Medplus Health Services Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent day gain of 2.55%, the stock’s technical indicators present a complex picture, with bullish signals on some fronts and bearish or neutral cues on others, reflecting a cautious market sentiment towards the retailing sector player.
Read full news articleAre Medplus Health Services Ltd latest results good or bad?
2026-01-31 19:29:52MedPlus Health Services Ltd reported its financial results for Q3 FY26, showcasing a significant topline performance but also highlighting challenges related to margin compression. The company achieved record net sales of ₹1,806.12 crores, reflecting a sequential growth of 7.55% and a year-on-year increase of 15.67%. This growth indicates strong demand across its pharmacy network and successful store expansions, particularly in tier-2 and tier-3 cities. However, despite the revenue growth, MedPlus experienced a slight decline in its operating margin, which fell to 8.78% from 8.86% in the previous quarter. This marginal contraction suggests that rising operational costs, particularly in employee expenses, are impacting profitability. The net profit for the quarter reached ₹57.81 crores, representing a sequential increase of 4.16% and a year-on-year growth of 25.98%. The profit after tax (PAT) margin stood a...
Read full news article
Medplus Health Services Ltd is Rated Sell
2026-01-31 10:10:20Medplus Health Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
MedPlus Health Services Q3 FY26: Margin Pressures Persist Despite Revenue Growth
2026-01-30 21:34:39MedPlus Health Services Ltd., one of India's leading pharmacy retail chains, reported consolidated net profit of ₹57.81 crores for Q3 FY26 (October-December 2025), marking a modest sequential increase of 4.16% from ₹55.50 crores in Q2 FY26 and a stronger year-on-year growth of 25.98% from ₹45.89 crores in Q3 FY25. The stock reacted positively, surging 3.33% to ₹798.00 on January 30, 2026, though it remains 24.15% below its 52-week high of ₹1,052.05. With a market capitalisation of ₹9,243 crores, MedPlus continues to expand its retail footprint, but profitability metrics reveal persistent challenges in sustaining margin improvements.
Read full news articleMedplus Health Services Ltd Falls 6.81%: Downgrade and Mixed Technical Signals Shape the Week
2026-01-24 11:02:34
Key Events This Week
Jan 19: Stock opens at ₹813.80, down 2.23% amid market weakness
Jan 20: Downgrade to Sell rating announced; stock closes at ₹798.75 (-1.85%)
Jan 21: Technical momentum shifts to mildly bearish; stock closes at ₹784.45 (-1.79%)
Jan 22: Slight recovery with 0.61% gain to ₹789.25
Jan 23: Week ends with a 1.72% drop to ₹775.65
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
04-Feb-2026 | Source : BSESubmission of Transcript of Earnings Call
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
04-Feb-2026 | Source : BSEUpdate under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
31-Jan-2026 | Source : BSEUpdate under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






